Lv3
280 积分 2024-10-29 加入
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
2个月前
已完结
Cancer incidence and mortality in China, 2022
2个月前
已完结
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study
2个月前
已完结
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
2个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2个月前
已完结
Abstract 5946: Five-year real-world survival outcomes of patients with advanced non-small cell lung cancer receiving first-line immunotherapy-based regimens
2个月前
已关闭
Abstract 5946: Five-year real-world survival outcomes of patients with advanced non-small cell lung cancer receiving first-line immunotherapy-based regimens
3个月前
已关闭
Five-year real-world survival outcomes of patients with advanced non-small cell lung cancer receiving first-line immunotherapy-based regimens
3个月前
已关闭
Abstract 5946: Five-year real-world survival outcomes of patients with advanced non-small cell lung cancer receiving first-line immunotherapy-based regimens
3个月前
已关闭
Five‐year lung cancer survival
3个月前
已完结
皖公网安备34019202002308
